Search

Search Results
Results 511 - 520 of 821 for Male breast cancer
  • Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Testavan intended for persons living in Australia.
  • News - 23 Feb 2026
    After a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Sadia Zapp was anxious — not the manageable hum that had long been part of her life, but something deeper, more...
  • News - 19 Jan 2026
    A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to hereditary cancer and familial hypercholesterolaemia, identifying clinically...
  • Drug - 9 Jan 2026
    Consumer Medicine Information (CMI) about Finasteride Viatris 5 intended for persons living in Australia.
  • News - 16 Dec 2025
    Pathology has long been the cornerstone of cancer diagnosis and treatment. A pathologist carefully examines an ultrathin slice of human tissue under a microscope for clues that indicate the presence,...
  • Drug - 10 Nov 2025
    Consumer Medicine Information (CMI) about DBL Vincristine Sulfate Injection intended for persons living in Australia.
  • Drug - 3 Oct 2025
    Consumer Medicine Information (CMI) about DBL Docetaxel intended for persons living in Australia.
  • Drug - 25 Sep 2025
    Consumer Medicine Information (CMI) about Adriamycin intended for persons living in Australia.
  • Drug - 27 Mar 2025
    Consumer Medicine Information (CMI) about Lynparza Tablets intended for persons living in Australia.
  • News - 20 Nov 2024
    Researchers find bread consumption is not linked to cancer risk, with whole-grain bread potentially reducing colorectal cancer and total cancer mortality.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.